This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Feb 10;41(5):1150-1151.

doi: 10.1200/JCO.22.02126. Epub 2022 Oct 31.

Reply to X. Luo et al

Veda N Giri¹, Thomas K Oliver¹, R Bryan Rumble¹, Rachel L Geisel¹

Affiliations

Affiliation

¹ Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA.

PMID: 36315930
DOI: 10.1200/JCO.22.02126

Comment

Reply to X. Luo et al

Veda N Giri et al. J Clin Oncol. 2023.

. 2023 Feb 10;41(5):1150-1151.

doi: 10.1200/JCO.22.02126. Epub 2022 Oct 31.

Authors

Veda N Giri¹, Thomas K Oliver¹, R Bryan Rumble¹, Rachel L Geisel¹

Affiliation

¹ Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA.

PMID: 36315930
DOI: 10.1200/JCO.22.02126

No abstract available

PubMed Disclaimer

Comment on

The Methodology of the ASCO Living Guidelines Should Be Improved and Refined.
Luo X, Lv M, Chen Y. Luo X, et al. J Clin Oncol. 2023 Feb 10;41(5):1149-1150. doi: 10.1200/JCO.22.01871. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315925 No abstract available.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.